Search results
Author(s):
Martin R Cowie
,
Holger Woehrle
,
Olaf Oldenburg
,
et al
Added:
3 years ago
Heart Failure
In developed countries, approximately 1–2 % of the adult population has heart failure (HF), and the prevalence of this cardiovascular disease increases with age.1,2 HF can occur in the presence or absence of reduced left ventricular ejection fraction (LVEF), known as HF with reduced ejection fraction (HF-rEF) and HF with preserved ejection fraction (HF-pEF), respectively. The most…
View more
Author(s):
Ali Vazir
,
Kostantinos Bronis
,
Simon G Pearse
Added:
3 years ago
Central sleep apnoea (CSA) is characterised by cycles of apnoea, hypopnoea and hyperpnoea during sleep due to abnormalities in the regulation of breathing within the respiratory centre in the brainstem. CSA, defined as an apnoea–hypopnoea index (AHI) of ≥15 events/h, is common in patients with heart failure (HF), with a prevalence of 20–45 %.1, 2 Its presence is reported to be a marker of…
View more
Sleep-Disordered Breathing During Congestive Heart Failure: To Intervene or Not to Intervene?
Author(s):
Ali Valika
,
Maria Rosa Costanzo
Added:
3 years ago
Article
Author(s):
William T Abraham
,
Adam Pleister
,
Robin Germany
Added:
3 years ago
Central sleep apnoea (CSA) occurs in approximately one-third of patients with HF and is associated with a significant increase in morbidity and mortality compared to HF patients without CSA.1–3 CSA results in intermittent hypoxia and activation of the renin–angiotensin system, which contributes to worsening HF.4 Symptoms such as fatigue and difficulty concentrating often overlap with the effects…
View more
Author(s):
Douglas Bradley
Added:
1 year ago
ESC 22 - In this short interview filmed onsite at ESC Congress 2022, Dr Douglas Bradley (University of Toronto, Toronto, CA) discusses the findings of the ADVENT-HF Trial (NCT01128816).
ADVENT-HF was designed to determine if a respiratory device, Adaptive Servo Ventilation can reduce the risk of cardiovascular hospitalisations and death in patients with heart failure and sleep apnoea. 732…
View more
Author(s):
Ernest Spitzer
,
Ben Ren
,
Felix Zijlstra
,
et al
Added:
3 years ago
Left ventricular ejection fraction (LVEF) is the most widely used parameter of left ventricular (LV) systolic function, and its deterioration is associated with reduced survival rates.1 LVEF is expressed as a percent value, and calculated by dividing the stroke volume (enddiastolic volume minus end-systolic volume) by the end-diastolic volume and multiplying by 100; however, volume measurements…
View more
ESC 22: Late-breaking Science Collection
Video Series
Foreword
Author(s):
Andrew JS Coats
,
Giuseppe Rosano
Added:
3 years ago
Article
Author(s):
Edoardo Bertero
,
Pietro Ameri
,
Christoph Maack
Added:
3 years ago
Heart failure (HF) and cancer represent two major causes of morbidity and mortality in developed countries.1,2 The prevalence of these conditions is growing as the age of the population and the burden of shared risk factors, such as diabetes and obesity, are constantly increasing. In past decades, the field of cardio-oncology has predominantly focused on prevention and treatment of cardiovascular…
View more
Author(s):
Nadja Scherbakov
,
Wolfram Doehner
Added:
3 years ago
Heart failure (HF) is a complex clinical syndrome with more than 15 million diagnosed cases worldwide.1,2 Characterised by structural or functional impairment of ventricular filling or ejection fraction (EF)3, HF is frequently accompanied by multiple comorbidities. Brain disorders, including stroke, mental disturbances and cognitive impairment are distinct from the comorbidities traditionally…
View more